- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07695480
Metabolic Effects of Diet-Exercise Interventions in Obesity
8. juli 2026 opdateret af: Elif Subaşı, Firat University
Metabolic Responses of Diet-Exercise Combinations in Women With Obesity: A Comparative Lifestyle Intervention Study With Different Diet Types
This study investigates the effects of different dietary strategies (ketogenic diet, intermittent fasting, and semi-vegetarian diet), alone or in combination with a structured home-based exercise program, on anthropometric, metabolic, and hormonal parameters in women with obesity.
A total of 108 participants aged 19-45 years are allocated into nine groups, including control, exercise-only, diet-only, and combined intervention groups.
Anthropometric outcomes (body weight, body mass index, and body fat percentage) and biochemical markers (glucose, insulin, adiponectin, IGF-1, irisin, and myostatin) are assessed at baseline and after a 6-week intervention period using bioelectrical impedance analysis and ELISA methods.
Studieoversigt
Status
Afsluttet
Betingelser
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
108
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Elâzığ, Tyrkiet (Türkiye), 23000
- Fırat University Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Medically and physically fit for exercise interventions.
- No participation in any structured dietary programs within the previous 3 months.
- Lack of orthopedic limitations that would prevent safe physical activity.
Exclusion Criteria:
- Pregnancy or lactation.
- Chronic conditions such as cancer, renal failure, or hepatic failure.
- Diagnosed psychiatric disorders.
- History of adverse reactions to venipuncture.
- Inability or unwillingness to adhere to the assigned dietary and exercise intervention protocols.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Ikke-randomiseret
- Interventionel model: Faktoriel opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Control (C)
This group consists of 12 individuals with normal weight who do not receive any dietary or exercise interventions.
They maintain their habitual lifestyle, physical activity, and dietary patterns for 6 weeks.
|
|
|
Ingen indgriben: Obese (O)
This group consists of 12 individuals with obesity who do not receive any dietary or exercise interventions.
They maintain their regular lifestyle, physical activity, and dietary habits for 6 weeks.
|
|
|
Eksperimentel: Obese with exercise (OE)
This group consists of 12 individuals with obesity who participate in a structured home-based exercise program for 6 weeks, without any dietary modifications.
|
A 6-week structured home-based exercise program consisting of moderate-intensity activities designed for weight management and metabolic improvement.
Andre navne:
|
|
Eksperimentel: Obese with exercise plus semi-vegetarian diet (OEVD)
This group consists of 12 individuals with obesity who follow a structured semi-vegetarian dietary protocol combined with a home-based exercise program for 6 weeks.
|
A 6-week structured home-based exercise program consisting of moderate-intensity activities designed for weight management and metabolic improvement.
Andre navne:
A 6-week structured semi-vegetarian dietary protocol primarily based on plant foods with occasional inclusion of meat or fish, designed for caloric control and metabolic tracking.
Andre navne:
|
|
Eksperimentel: Obese with semi-vegetarian diet (OVD)
This group consists of 12 individuals with obesity who follow a structured semi-vegetarian dietary protocol for 6 weeks, without participating in any exercise program.
|
A 6-week structured semi-vegetarian dietary protocol primarily based on plant foods with occasional inclusion of meat or fish, designed for caloric control and metabolic tracking.
Andre navne:
|
|
Eksperimentel: Obese with exercise plus intermittent fasting (OEIF)
This group consists of 12 individuals with obesity who follow a structured intermittent fasting protocol combined with a home-based exercise program for 6 weeks.
|
A 6-week structured home-based exercise program consisting of moderate-intensity activities designed for weight management and metabolic improvement.
Andre navne:
A 6-week structured intermittent fasting protocol regulating specific eating and fasting windows each day to evaluate its effects on body composition and metabolic markers.
Andre navne:
|
|
Eksperimentel: Obese with intermittent fasting (OIF)
This group consists of 12 individuals with obesity who follow a structured intermittent fasting protocol for 6 weeks, without participating in any exercise program.
|
A 6-week structured intermittent fasting protocol regulating specific eating and fasting windows each day to evaluate its effects on body composition and metabolic markers.
Andre navne:
|
|
Eksperimentel: Obese with exercise plus ketogenic diet (OEKD)
This group consists of 12 individuals with obesity who follow a structured ketogenic dietary protocol combined with a home-based exercise program for 6 weeks.
|
A 6-week structured home-based exercise program consisting of moderate-intensity activities designed for weight management and metabolic improvement.
Andre navne:
A 6-week structured ketogenic dietary protocol characterized by high-fat, adequate-protein, and very low-carbohydrate intake to induce nutritional ketosis.
Andre navne:
|
|
Eksperimentel: Obese with ketogenic diet (OKD)
This group consists of 12 individuals with obesity who follow a structured ketogenic dietary protocol for 6 weeks, without participating in any exercise program.
|
A 6-week structured ketogenic dietary protocol characterized by high-fat, adequate-protein, and very low-carbohydrate intake to induce nutritional ketosis.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Body Weight
Tidsramme: Baseline and 6 weeks
|
Body weight will be measured in kilograms (kg) using a calibrated Bioelectrical Impedance Analysis (BIA) device (Omron Karadascan HBF-511, Japan).
The outcome will evaluate the effectiveness of the 6-week lifestyle interventions on body mass reduction compared to baseline.
|
Baseline and 6 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Body Mass Index (BMI)
Tidsramme: Baseline and week 6
|
Body Mass Index will be calculated using the formula weight in kilograms divided by height in meters squared (kg/m²).
Height will be measured using a stadiometer (Holtain Ltd., UK) and weight via a Bioelectrical Impedance Analysis (BIA) device (Omron Karadascan HBF-511, Japan).
|
Baseline and week 6
|
|
Change in Body Fat Percentage
Tidsramme: Baseline and week 6
|
Body fat percentage (%) will be measured using a Bioelectrical Impedance Analysis (BIA) device (Omron Karadascan HBF-511, Japan) to evaluate the proportion of fat tissue relative to total body weight.
|
Baseline and week 6
|
|
Change in Skeletal Muscle Percentage
Tidsramme: Baseline and week 6
|
Skeletal muscle percentage (%) will be measured using a Bioelectrical Impedance Analysis (BIA) device (Omron Karadascan HBF-511, Japan) to evaluate the proportion of muscle tissue relative to total body weight.
|
Baseline and week 6
|
|
Change in Fasting Blood Glucose
Tidsramme: Baseline and week 6
|
Fasting blood glucose levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) method from venous blood samples to evaluate the effects of the interventions on glycemic control.
|
Baseline and week 6
|
|
Change in Fasting Insulin
Tidsramme: Baseline and week 6
|
Fasting insulin levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) method from venous blood samples to assess pancreatic beta-cell function and insulin dynamics.
|
Baseline and week 6
|
|
Change in Adiponectin Levels
Tidsramme: Baseline and week 6
|
Serum adiponectin levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to evaluate changes in adipokine secretion and insulin sensitivity.
|
Baseline and week 6
|
|
Change in Insulin-Like Growth Factor 1 (IGF-1) Levels
Tidsramme: Baseline and week 6
|
Serum IGF-1 levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to evaluate alterations in growth hormone axis and metabolic adaptation.
|
Baseline and week 6
|
|
Change in Irisin Levels
Tidsramme: Baseline and week 6
|
Serum irisin levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to track changes in myokine secretion in response to physical activity and dietary interventions.
|
Baseline and week 6
|
|
Change in Myostatin Levels
Tidsramme: Baseline and week 6
|
Serum myostatin levels will be analyzed via Enzyme-Linked Immunosorbent Assay (ELISA) from venous blood samples to assess skeletal muscle mass regulation and myokine alterations.
|
Baseline and week 6
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
30. juli 2023
Primær færdiggørelse (Faktiske)
15. december 2023
Studieafslutning (Faktiske)
12. januar 2024
Datoer for studieregistrering
Først indsendt
1. juli 2026
Først indsendt, der opfyldte QC-kriterier
8. juli 2026
Først opslået (Faktiske)
10. juli 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
10. juli 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
8. juli 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Ernæringsforstyrrelser
- Overernæring
- Kropsvægt
- Overvægtig
- Patologiske tilstande, tegn og symptomer
- Opførsel
- Ernæringsmæssige og metaboliske sygdomme
- Tegn og symptomer
- Fodringsadfærd
- Fedme
- Faste
- Terapeutik
- Diæt, mad og ernæring
- Fysiologiske fænomener
- Ernæringsfysiologiske fænomener
- Diætterapi
- Ernæringsterapi
- Kost
- Diæt, kulhydratbegrænset
- Diæt, ketogen
Andre undersøgelses-id-numre
- FSU-OBES-DIETEX-2026-01
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
IPD-planbeskrivelse
İndividual participant data will not be shared because participant consent for public data sharing was not obtained.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Home-Based Exercise Program
-
Penn State UniversityRekrutteringAutismespektrumforstyrrelseForenede Stater
-
Mersin UniversityAfsluttetAfhængighed af sociale medierKalkun
-
Unity Health TorontoCovenant House Toronto; StepStones for Youth; Resource Association for TeensAfsluttet
-
Sheba Medical CenterAfsluttetArvelig bryst- og ovariecancersyndromIsrael
-
Sheba Medical CenterUkendtArvelig bryst- og ovariecancersyndromIsrael
-
Centre Hospitalier EsquirolAfsluttetErhvervet hjerneskade | Cerebral Parese InfantilFrankrig
-
Istanbul Medipol University HospitalRekruttering
-
Centre for Research and Technology HellasAHEPA University Hospital; Theagenio Cancer Hospital; Hellenic Cancer SocietyRekrutteringBrystkræft | Tyktarmskræft | Hoved- og halskræftGrækenland
-
University of Modena and Reggio EmiliaAfsluttetSygeplejerskeuddannelsen | Uddannelse, Kompetencebaseret | Uddannelse, Sygeplejestuderende | Aktive læringsmetoder og undervisning i livsfærdigheder | Evidensbaseret praksis | Evidensbaserede programmer i skoler | Uddannelsesfremme | Evidensbaseret sygepleje | Sygeplejerskeuddannelse i Evidensbaseret PraksisItalien